Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antibiotic-Resistant Gram-Negative Bacteria (R01)

The purpose of this grant is to support milestone-driven projects focused on developing and utilizing novel predictive models, assays, tools, and/or platforms based on penetration and efflux of small molecules to facilitate therapeutic discovery for select Gram-negative bacterial pathogens:

• carbapenem-resistant Acinetobacter
• carbapenem-resistant Enterobacterales (CRE)
• multidrug-resistant Pseudomonas aeruginosa.

Funding: $750,000 per year

Duration: 5 years 

Research Authority fdue date: 10.7.24

LIO (encouraged) due date: 20.7.24

Full proposal due date:20.8.24